Paul Abu-Rabie

Paul Abu-Rabie has been part of the Drug Metabolism and Pharmacokinetics (DMPK) group at GlaxoSmithKline, Ware, UK, for the last 10 years. He is currently a technical leader in the Bioanalytical Science and Toxicokinetics (BST) department supporting small molecule and biopharm applications. His main areas of interest include the development of new technology and innovations in bioanalysis, particularly in mass spectrometry, microsampling and direct analysis. Paul received a degree in Chemistry in 1998 from the University of Sussex, UK. He is currently undertaking a PhD on the topic of direct analysis under the tutorship of Professor Frank Pullen at Greenwich University, UK.